skills/pharmolix/openbiomed/drug-lead-analysis/Snyk

drug-lead-analysis

Pass

Audited by Snyk on Mar 25, 2026

Risk Level: LOW

Full Analysis

No issues detected.

Audit Metadata

Risk Level

LOW

Analyzed

Mar 25, 2026, 05:57 AM